Combination therapy involving ciprofloxacin for peritonitis

Peritoneal Dialysis International

Volumn 16, Issue 3, 1996, Pages 316-317

  Guest, Steven S ^a   Erickson, Loree J ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; VANCOMYCIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORBIDITY; ORAL DRUG ADMINISTRATION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL;

EID: 0029994553     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600314     Document Type: Article

References (6)

1. Keane WF, Everett ED, Golper TA, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Perit Dial Int 1993; 13:14-28.
2. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med 1991; 324:384-94.
3. Fleming LW, Moreland TA, Scott AC, et al. Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1987; 19:493-503.
4. Waite NM, Johnson MD, Webster NR, et al. Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. Perit Dial Int 1993; 13:50-4.
5. Tapson JS, Orr KE, Stansfield E, et al. A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis. J Antimicrob Chemother 1990; 26(Suppl F):63-71.
6. Golper TA, Hartstein AI, Morthland VH, et al. Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987; 31:1787-90.